Citation map · Study

The current status of nucleic acid amplification technology in transfusion‐transmitted infectious disease testing

10 references·1 citing·43 second hop

this work references cited by second hop

References

2009Infectivity of human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion221 cited
2010Refinement of a viral transmission risk model for blood donations in seroconversion window phase screened by nucleic acid testing in different pool sizes and repeat test algorithms131 cited
2009Experience of mandatory nucleic acid test (NAT) screening across all blood organizations in Germany: NAT yield versus breakthrough transmissions73 cited
2008Comparison of the analytical and operational performance of two viral nucleic acid test blood screening systems: Procleix Tigris and cobas s 20152 cited
2013Prevalence of human immunodeficiency virus RNA and antibody in first‐time, lapsed, and repeat blood donations across five international regions and relative efficacy of alternative screening scenarios50 cited
2014Infectivity of blood components from donors with occult hepatitis B infection – results from an Australian lookback programme49 cited
2013How safe is safe: new human immunodeficiency virus Type 1 variants missed by nucleic acid testing30 cited
2012Evaluation of two, commercial, multi‐dye, nucleic acid amplification technology tests, for HBV/HCV/HIV‐1/HIV‐2 and B19V/HAV, for screening blood and plasma for further manufacture27 cited
2013Human immunodeficiency virus transfusion transmission despite nucleic acid testing24 cited
2014First report of human immunodeficiency virus transmission via a blood donation that tested negative by 20‐minipool nucleic acid amplification in J apan9 cited

Cited by

2019Safe-Testing Algorithm for Individual-Donation Nucleic Acid Testing: 10 Years of Experience in a Low-Prevalence Country

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work